The variability of episodic memory decline and hippocampal atrophy observed with increasing age may partly be explained by genetic factors. KIBRA (kidney and brain expressed protein) and CLSTN2 (calsyntenin 2) are two candidate genes previously linked to episodic memory performance and volume of the hippocampus, a key memory structure. However, whether polymorphisms in these two genes also influence age-related longitudinal memory decline and hippocampal atrophy is still unknown. Using data from two independent cohorts, the Sydney Memory and Ageing Study and the Older Australian Twins Study, we investigated whether the KIBRA and CLSTN2 genetic polymorphisms (rs17070145 and rs6439886) are associated with episodic memory performance and hippocampal volume in older adults (65-90 years at baseline). We were able to examine these polymorphisms in relation to memory and hippocampal volume using cross-sectional data and, more importantly, also using longitudinal data (2 years between testing occasions). Overall we did not find support for an association of KIBRA either alone or in combination with CLSTN2 with memory performance or hippocampal volume, nor did variation in these genes influence longitudinal memory decline or hippocampal atrophy in two cohorts of older adults.
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Introduction
Episodic memory declines with age (Rönnlund et al., 2005 ) and yet our current understanding of the underlying biological processes is rudimentary. Heritability estimates of 30-60% for memory suggest that genetics plays a major role in memory performance (McClearn et al., 1997; Papassotiropoulos and de Quervain, 2011) . Despite significant heritability, only a small number of genes have consistently been associated with memory performance and the diversity of the results is striking. The first GWAS of episodic memory function resulted in the identification of KIBRA, kidney and brain expressed protein (also known as WW and C2 domain containing 1, WWC1), as a candidate gene affecting memory performance as well as functional brain activity based on three separate cohorts within the age range of 18-81 years (Papassotiropoulos et al., 2006) . From this study a single nucleotide polymorphism (SNP) leading to a substitution of C-T 
